The selected cases include targets for the insomnia treatment: melatonin receptor 1 A (MTR1A), melatonin receptor 1B (MTR1B), orexin/hypocretin receptor type 1 (OX1R), orexin receptor type 2 (OX2R). This evidence concerns the gene HCRTR2 and insomnia measurement.